- Fee assured
- Verified this account
- Skin cancer
Dr. Katie Lacy is a Consultant Dermatologist at the St. John’s Institute of Dermatology, Guys and St. Thomas’ Hospital, London, an internationally recognised centre for the treatment of patients with skin conditions. She is experienced in treating patients with general dermatological conditions including eczema, psoriasis, acne, benign and cancerous skin lesions and other skin rashes.
She has a specialist interest in melanoma and is the clinical lead for the melanoma multidisciplinary team at Guys and St. Thomas’s Hospital. She runs a dedicated clinic for patients with multiple moles and has extensive experience of the use of mole mapping and dermoscopy in order to identify suspicious skin lesions. She also undertakes skin cancer genetics clinics jointly with the genetics department at Guy's Hospital.
Katie Lacy graduated from Pembroke College, Oxford University with a 1st class Honours degree. Having completed a PhD in skin immunology, she is currently an Honorary Senior Lecturer at Kings College London. She runs a research group investigating immune responses in melanoma and also has an interest in new techniques for skin cancer diagnosis including optical coherence tomography and confocal microscopy. She has published her work in journals and given presentations at national and international meetings.
Areas of interest
Skin cancer; melanoma; moles
Current NHS consultant posts held
Consultant Dermatologist, St. John's Institute for Dermatology, Guys and St. Thomas' Hospital, London. Clinical Specialist Melanoma Multidisciplinary Team Lead.
Immunology, melanoma, immunotherapy for melanoma, skin cancer imaging
Roger Bannister scholarship for highest marks in finals, Pembroke College Oxford 1994
Royal Society of Medicine Dermatology section best registrar oral presentation 2008.
Research grants awarded from British Skin Foundation, Dermatrust, NIHR.
1. Akbar AN, Reed JR, Lacy KE et al Investigation of the cutaneous response to recall antigen in humans in vivo. Clin Exp Immunol. 2013 Aug;173(2):163-72. doi: 10.1111/cei.12107
2. Geh JL, Healy C, Lacy K et al. Call for a balanced view on sentinel node biopsy for melanoma. BMJ. 2013 Feb 6;346:f648. doi: 10.1136/bmj.f648
3. Karaggianis P, Gilbert AE, Josephs D, Ali N, Dodev T, Saul L, Roberts L, Beddowes E, Koers A, Ferreira S, Geh J, Healy C, Harries M, Acland K, Blower PJ, Mitchell T, Fear DJ, Spicer JF, Lacy KE, Nestle FO, Karagiannis S. IgG4 subclass antibodies impair anti-tumor immunity in melanoma. J Clin Invest, 2013 (1); 123 (4):1457-74
4. Vukmanovic-Stejic M, Sandhu D, O.Sobande, Agius E, Lacy KE et al Varicella Zoster –Specific CD4+FoxP3+T cells accumulate after T,cutaneous antigen challenge in humans. Accepted for publication J Immunol Jan 2013, in print
5. Coleman A, Richardson T, Orchard G, Uddin A, Choi MJ, Mallipeddi R, Lacy KE. Histological correlates of Optical Coherence Tomography in non- melanoma skin cancer. Skin Res Technol 2012 Jun 28 Epub; 2013 19(1)e10-9.
6. Lacy KE, Karagiannis SN, Nestle FO. Advances in the treatment of melanoma. Clin Med 2012. 12(2):168-71
7. Lacy KE, Karagiannis SN, Nestle FO. Immunotherapy for melanoma. Expert Rev Dermatol, 2012Vol 7 (1):51-68 (18)
8. Laggner U, DiMeglio P, Hundhausen C, Perera GK, Lacy KE et al. Identification of a novel pro- inflammatory skin homing V gamma V delta 2 T cell subset with a potential role in psoriasis. J Immunol 187 (5):2783-93 (2011)
9. Gilbert AE, Karagiannis P, Dodev T, Koers A, Lacy K et al. Monitoring the systemic human memory B cell compartment of melanoma patients for anti- tumour IgG antibodies. PLoS One 29; 6(4): e19330 (2011)
10. Agius E, Lacy KE et al Decreased TNF-alpha synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging. J Exp Med 206: 1929-40 (2009) *First author (joint)
Courses offered to GPs
Talks on melanoma diagnosis, examination of moles, general dermatology.
- MA Natural Sciences, 1st class honours Oxford University 1994
- MBBS London 1997
- PhD University College London 2008
- FRCP Royal College of Physicians 2012
Details of entry to specialist register
- Specialist in Dermatology, 2008
- London Bridge Hospital, SE1 2PR
- 09:00 - 16:00
- 020 3282 1236
- The Shard Diagnostic Centre
- 11:00 - 13:00
- 020 3282 1236
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
Information for healthcare professionals (Bupa patients only, last 12 months)
Shave biopsy of lesion of skin - (5-50)
Excision of lesion of skin or subcutaneous tissue - up to three, Trunk & Limbs (excluding lipoma) - (5-50)
Curettage/cryotherapy of lesion of skin (including cauterisation) - up to three - (5-50)
Biopsy of skin or subcutaneous tissue - (5-50)
London Bridge Hospital (5-50)
Primary excision of malignant lesion - trunk & limbs - (1-5)
London Bridge Hospital (1-5)
- Show All (7)...